Renal replacement therapy neutralizes elevated MIF levels in septic shock

Julia Pohl1, Maria Papathanasiou1, Martin Heisler1

  • 1West-German Heart and Vascular Center Essen, Department of Cardiology and Department ofVascular Medicine, University Hospital Essen, Hufelandstr. 55, 45147 Essen, Germany.

Abstract

Insights

Continuous renal replacement therapy (CRRT) effectively reduced macrophage migration inhibitory factor (MIF) levels in septic shock patients. Lowering MIF through CRRT correlated with improved survival rates, suggesting a potential therapeutic strategy for severe sepsis.

Area of Science:

  • Critical Care Medicine
  • Immunology
  • Nephrology

Background:

  • Macrophage migration inhibitory factor (MIF) amplifies immune responses in sepsis, but clinical data on its role in septic patients are limited.
  • Renal replacement therapy (RRT) is explored for cytokine removal in sepsis.
  • MIF removal by RRT in chronic kidney disease suggests potential for septic shock patients.

Purpose of the Study:

  • To investigate if RRT can lower plasma levels of the pro-inflammatory cytokine MIF in septic shock patients.
  • To assess the impact of continuous RRT (CRRT) on MIF levels and mortality in septic shock with acute kidney injury (AKI).

Main Methods:

  • Observational, single-center study in an ICU involving 25 septic shock patients.
  • Assessed plasma MIF levels and mortality using a validated method.
  • Compared MIF levels and mortality between patients with and without CRRT for septic AKI.

Main Results:

  • CRRT significantly decreased plasma MIF levels in septic shock patients with AKI, indicating MIF removal by hemodialysis.
  • Patients undergoing CRRT showed lower MIF release (MIFAUC) and distinctly lower mortality.
  • Higher MIF levels and MIFAUC were associated with non-survival in septic shock.

Conclusions:

  • This study demonstrates efficient MIF removal from plasma in septic shock patients via CRRT.
  • Reduction of circulating MIF by CRRT correlated with improved survival.
  • Targeted MIF removal may be a promising therapeutic strategy to reduce mortality in severe sepsis.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...